U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07601763) titled 'A Randomized Controlled Trial of Pulsed Field Ablation for Atrial Fibrillation (POWER-AF)' on May 08, 2025.
Brief Summary: Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice. As of 2019, there were approximately 59.7 million patients with AF worldwide, including atrial flutter (AF). Atrial fibrillation can significantly increase the risks of stroke, thromboembolism and heart failure in patients, seriously affecting their quality of life.
Catheter ablation is the main means for rhythm control in patients with atrial fibrillation. A large number of clinical studies have confirmed the effectiveness and ...